To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene VKORC1andPRSS53TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
502 supporting clones for gene VKORC1andPRSS53 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AJ627035 fetal liver .a 1 to 1662 1 to 1662 exact tiling clone,   1662/1662
(100 %)
0 diff
(100 %id)
NM_001039503.2   .a 1 to 2028 1 to 2028 exact RefSeq,   2028/2028
(100 %)
0 diff
(100 %id)
F06579 brain, total brain .a 672 to 899 1 to 228       228/228
(100 %)
1 diff
(99.6 %id)
Z42936 brain, total brain .a 673 to 983 1 to 310       310/310
(100 %)
4 diff
(98.8 %id)
F06578 brain, total brain .a 673 to 901 1 to 229       229/229
(100 %)
3 diff
(98.7 %id)
R18052 whole brain .a 691 to 1008 1 to 319       319/319
(100 %)
9 diff
(97.2 %id)
BE206899 lung, small cell carcinoma .a 871 to 1035 1 to 165       165/173
(95 %)
3 diff
(98.3 %id)
R42951 whole brain .a 1622 to 2028 412 to 8   tiling clone,   405/414
(97 %)
0 diff
(100 %id)
BM471361 leiomyosarcoma, uterus .a 1663 to 2019 32 to 388   tiling clone, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 357/388
(92 %)
6 diff
(98.5 %id)
BX351871 Placenta Cot 25-normalized .a 1675 to 2011 340 to 1       340/422
(80 %)
19 diff
(95.5 %id)
AI868859 Prostate .a 1679 to 2014 337 to 1       337/337
(100 %)
2 diff
(99.5 %id)
AW452125   .a 1698 to 2019 341 to 20   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 322/334
(96 %)
0 diff
(100 %id)
BM671392 eye, Retina Foveal and Macular .a 1699 to 2019 339 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 321/330
(97 %)
0 diff
(100 %id)
BF057766 pooled germ cell tumors .a 1731 to 2022 293 to 1       293/293
(100 %)
2 diff
(99.4 %id)
D29609   .a 1736 to 2022 1 to 283       283/284
(99 %)
5 diff
(98.3 %id)
Z39054 brain, total brain .a 1742 to 2014 274 to 1       274/274
(100 %)
1 diff
(99.7 %id)
AW732053 lung, small cell carcinoma .a 1742 to 2028 287 to 1       287/287
(100 %)
7 diff
(97.6 %id)
F02851 brain, total brain .a 1751 to 2014 264 to 1       264/264
(100 %)
1 diff
(99.7 %id)
T16738   .a 1807 to 2026 221 to 1       221/221
(100 %)
1 diff
(99.6 %id)
F02850 brain, total brain .a 1829 to 2014 186 to 1       186/194
(95 %)
1 diff
(99.5 %id)
AY358456   .b 1 to 2362 1 to 2362 exact tiling clone,   2362/2365
(99 %)
2 diff
(100.0 %id)
FN051244 breast carcinoma .b 3 to 95 98 to 1     Submitted on the opposite strand 96/98
(97 %)
5 diff
(94.9 %id)
BG210087   .b 41 to 295 1 to 255       254/255
(99 %)
14 diff
(94.6 %id)
BQ347166 nervous_tumor .b 71 to 276 207 to 2       206/207
(99 %)
0 diff
(100 %id)
AA298843 thyroid gland .b 92 to 401 1 to 311       311/312
(99 %)
2 diff
(99.4 %id)
BQ327082 colon_normal .b 93 to 394 1 to 301       301/311
(96 %)
12 diff
(96.2 %id)
R36822   .b 231 to 380 1 to 150       150/156
(96 %)
1 diff
(99.4 %id)
EC487449 Prostate .b 244 to 332 8 to 94       87/94
(92 %)
2 diff
(97.9 %id)
BF750936 breast_normal .b 284 to 400 1 to 115       115/117
(98 %)
8 diff
(93.2 %id)
BE264142 lung, small cell carcinoma .b 1238 to 1744 1 to 507       507/507
(100 %)
1 diff
(99.9 %id)
CR747301 eye, retinoblastoma .b 1342 to 1810 12 to 480       469/480
(97 %)
6 diff
(98.8 %id)
AA431945   .b 1801 to 2028 1 to 207     Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 207/207
(100 %)
16 diff
(92.3 %id)
AA443827   .b 2060 to 2361 317 to 16   tiling clone, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 302/302
(100 %)
0 diff
(100 %id)
D20812   .b 2289 to 2579 291 to 1       291/295
(98 %)
0 diff
(100 %id)
BM144667 leukopheresis .b 2301 to 2749 6 to 454   AAA   449/454
(98 %)
6 diff
(98.7 %id)
BF911555 uterus_tumor .b 2304 to 2706 10 to 412       403/544
(74 %)
2 diff
(99.7 %id)
BP395894 pancreatic islet .b 2334 to 2776 444 to 1       444/444
(100 %)
2 diff
(99.6 %id)
AW973524   .b 2338 to 2783 1 to 446   tiling clone,   446/450
(99 %)
1 diff
(99.8 %id)
DA322294 hippocampus .c 1 to 574 2 to 575   tiling clone, capped   574/574
(100 %)
0 diff
(100 %id)
DA322325 hippocampus .c 1 to 570 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
AK131087 Spleen .c 405 to 5894 1 to 5491 exact tiling clone, available from FLJ,   5491/5491
(100 %)
13 diff
(99.8 %id)
DA319155 hippocampus .c 469 to 1027 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BF934045 nervous_tumor .c 707 to 1166 1 to 460       460/472
(97 %)
10 diff
(97.9 %id)
DA228138 brain .c 1308 to 1777 2 to 471   capped   470/470
(100 %)
3 diff
(99.4 %id)
CN286730 embryonic stem cells, cell lines H1, H7, andH9 .c 1598 to 1846 1 to 249       249/249
(100 %)
2 diff
(99.2 %id)
DA267519 caudate nucleus .c 1748 to 2282 2 to 537   tiling clone, capped   536/536
(100 %)
3 diff
(99.5 %id)
DY655103 pooled .c 1759 to 1968 133 to 342       210/342
(61 %)
6 diff
(98.3 %id)
DA779242 brain .c 3594 to 4163 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
BF989712 placenta_normal .c 3780 to 4050 271 to 1       271/271
(100 %)
1 diff
(99.7 %id)
BF992554 placenta_normal .c 3780 to 4050 271 to 1       271/271
(100 %)
3 diff
(98.9 %id)
BF992560 placenta_normal .c 3780 to 3891 114 to 3       112/114
(98 %)
0 diff
(100 %id)
BF993836 placenta_normal .c 3780 to 4050 271 to 1       271/271
(100 %)
1 diff
(99.7 %id)
BG819317 anaplastic oligodendroglioma with 1p/19qloss, brain .c 4110 to 4811 1 to 702   tiling clone,   702/705
(99 %)
6 diff
(99.2 %id)
BM719408 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 5136 to 5519 1 to 384   fully sequenced, Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 384/384
(100 %)
4 diff
(99.0 %id)
AA258734 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 5195 to 5460 1 to 265       265/265
(100 %)
1 diff
(99.7 %id)
BQ774545 Chondrosarcoma Grade II, Left Pelvis .c 5313 to 5894 601 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 583/583
(100 %)
5 diff
(99.2 %id)
AA528252 breast .c 5316 to 5893 578 to 1       578/578
(100 %)
8 diff
(98.7 %id)
DB305305 brain .c 5373 to 5913 542 to 1   tiling clone,   542/542
(100 %)
4 diff
(99.3 %id)
BX112785 whole brain .c 5378 to 5901 544 to 21   tiling clone, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 524/525
(99 %)
0 diff
(100 %id)
CA423893 cell lines, Chondrosarcoma .c 5399 to 5894 512 to 17   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 496/496
(100 %)
1 diff
(99.8 %id)
DB309172 hippocampus .c 5447 to 5899 456 to 1       456/456
(100 %)
8 diff
(98.3 %id)
BX359184 Placenta Cot 25-normalized .c 5465 to 5887 1 to 426   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 426/426
(100 %)
21 diff
(95.1 %id)
CR618714 Placenta Cot 25-normalized .c 5466 to 5908 1 to 443       443/443
(100 %)
0 diff
(100 %id)
BX359183 Placenta Cot 25-normalized .c 5466 to 5867 405 to 1       405/406
(99 %)
15 diff
(96.4 %id)
BQ773924 Chondrosarcoma Grade II, Left Pelvis .c 5509 to 5894 405 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 387/387
(100 %)
3 diff
(99.3 %id)
BM684239 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 5513 to 5894 399 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 383/383
(100 %)
1 diff
(99.8 %id)
DB326148 brain .c 5534 to 5894 364 to 1       364/367
(99 %)
3 diff
(99.2 %id)
AA258579 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 5719 to 5871 153 to 1       153/153
(100 %)
0 diff
(100 %id)
BQ437135 eye, retinoblastoma .d 1 to 737 1 to 748 L222P L223P P224A N225K A227L ... tiling clone,   748/796
(93 %)
13 diff
(98.4 %id)
CB163861 Liver .e 1 to 653 1 to 653   tiling clone,   653/653
(100 %)
1 diff
(99.9 %id)
N44247 melanocyte .e 93 to 352 1 to 258       258/258
(100 %)
9 diff
(96.6 %id)
CN484751 eye .e 129 to 755 1 to 627   tiling clone,   627/628
(99 %)
1 diff
(99.9 %id)
N76364 multiple sclerosis lesions .e 150 to 324 1 to 170       168/170
(98 %)
10 diff
(94.2 %id)
BM697994 eye, fetal eyes .e 178 to 657 1 to 480     Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 480/480
(100 %)
0 diff
(100 %id)
N36015 melanocyte .e 635 to 980 347 to 1       347/347
(100 %)
1 diff
(99.8 %id)
N59833 multiple sclerosis lesions .e 635 to 991 364 to 1   tiling clone,   364/440
(82 %)
10 diff
(97.8 %id)
BM667161 eye, fetal eyes .e 690 to 980 309 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 291/291
(100 %)
0 diff
(100 %id)
DA115542 cerebellum .f 88 to 642 2 to 556   tiling clone, capped   555/555
(100 %)
0 diff
(100 %id)
BX644781   .f 317 to 1103 1 to 786 E199X N207T T208Q A209L A210L ... tiling clone,   786/786
(100 %)
1 diff
(99.9 %id)
DY655104 pooled .f 341 to 755 415 to 1       654/683
(95 %)
11 diff
(98.4 %id)
DY655130 pooled .f 345 to 725 381 to 1       674/726
(92 %)
11 diff
(98.5 %id)
CB987243 Pooled-Glandular .g 1 to 514 1 to 516   tiling clone,   516/869
(59 %)
10 diff
(98.9 %id)
DB164391 thymus .g 18 to 599 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
AA297517 epithelium, skin .g 52 to 319 1 to 269       269/271
(99 %)
2 diff
(99.3 %id)
BG708623 brain, hypothalamus .g 52 to 346 1 to 294       294/294
(100 %)
6 diff
(98.0 %id)
CB108541 Liver .g 58 to 523 1 to 468       466/468
(99 %)
4 diff
(99.2 %id)
BM313500 Pancreas, Purified pancreatic islet .g 69 to 526 1 to 458       458/458
(100 %)
0 diff
(100 %id)
CB069035 Pancreas, Purified pancreatic islet .g 81 to 492 7 to 418       410/418
(98 %)
6 diff
(98.6 %id)
TI_154196988   .g 93 to 710 14 to 633       620/1051
(58 %)
21 diff
(98.1 %id)
TI_154196604   .g 97 to 826 19 to 747 E122D Q126H A127V G133* tiling clone,   727/1054
(68 %)
34 diff
(96.8 %id)
N32448 melanocyte .g 100 to 522 1 to 424       424/462
(91 %)
12 diff
(97.5 %id)
CB119185 Liver .g 111 to 438 1 to 330       330/330
(100 %)
3 diff
(99.1 %id)
TI_154195452   .g 142 to 827 1 to 688 G95C Q100H P120S G121V Q126* tiling clone,   688/1027
(66 %)
44 diff
(95.8 %id)
DA711817   .g 177 to 741 2 to 568   tiling clone, capped   567/567
(100 %)
2 diff
(99.7 %id)
AA298624 lung .g 264 to 523 1 to 261       261/261
(100 %)
5 diff
(98.1 %id)
AK125618 Spleen .h-u 1 to 2217 2 to 2218 exact tiling clone, available from FLJ,   2218/2218
(100 %)
5 diff
(99.8 %id)
DA952756 Spleen .h-u 1 to 553 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
BP284597 bone marrow .h-u 975 to 1598 1 to 624   tiling clone,   624/624
(100 %)
0 diff
(100 %id)
DB333851 Spleen .h-u 1913 to 2217 305 to 1       305/307
(99 %)
0 diff
(100 %id)
TI_57201755   .i 1 to 963 54 to 1020 Q157P K159Q A160G K161* tiling clone,   967/1048
(92 %)
35 diff
(96.7 %id)
CN256411 embryonic stem cells, cell lines H1, H7, andH9 .i 4 to 538 4 to 538       533/538
(99 %)
7 diff
(98.7 %id)
BI822140 pooled brain, lung, testis .i 6 to 963 1 to 962 Q157P K159Q A160G K161*     962/990
(97 %)
27 diff
(97.3 %id)
NM_024006.4   .i 6 to 1002 1 to 997 exact RefSeq, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 997/997
(100 %)
0 diff
(100 %id)
BP215778 corpus callosum .i 15 to 595 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
AY466113   .i 21 to 1002 1 to 983 exact tiling clone, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 983/983
(100 %)
2 diff
(99.8 %id)
CA951080 Pancreas, Purified pancreatic islet .i 23 to 545 1 to 525   fully sequenced,   525/525
(100 %)
2 diff
(99.7 %id)
CN256416 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 27 to 580 1 to 554       554/554
(100 %)
0 diff
(100 %id)
BE313144 brain, neuroblastoma .i 34 to 826 1 to 792 C132L I133H V134C C135L I136Y ...     792/799
(99 %)
14 diff
(98.3 %id)
BG499438 adenocarcinoma, Prostate .i 34 to 914 1 to 873 R100T W101L A102G S103L V104C ...     873/894
(97 %)
29 diff
(96.8 %id)
BP302729   .i 35 to 630 1 to 601       601/603
(99 %)
8 diff
(98.7 %id)
AW961121   .i 41 to 615 1 to 571       571/572
(99 %)
22 diff
(96.2 %id)
BG769610 melanotic melanoma, high MDR (cell line), skin .i 43 to 925 1 to 886 C16L L17P T18D V21S L22A ...     884/956
(92 %)
49 diff
(94.9 %id)
CN256415 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 45 to 660 1 to 616       616/616
(100 %)
0 diff
(100 %id)
DA511785 brain .i 46 to 613 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
AK312005 brain .i 49 to 723 1 to 675 exact     675/675
(100 %)
0 diff
(100 %id)
DA511762 brain .i 49 to 602 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA511851 brain .i 50 to 605 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BP316367 pericardium .i 50 to 631 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
BF969005 adrenal cortex carcinoma, cell line, adrenal gland .i 54 to 783 9 to 748 G2A S3A T4P W5G R12L ...     738/748
(98 %)
12 diff
(98.4 %id)
CN256410 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i 55 to 670 7 to 623       615/623
(98 %)
7 diff
(98.9 %id)
CA867499 Pancreas, Purified pancreatic islet .i 57 to 545 1 to 489   fully sequenced,   489/489
(100 %)
0 diff
(100 %id)
W95282 heart .i 63 to 501 1 to 454       451/466
(96 %)
20 diff
(95.8 %id)
BE260130 brain, neuroblastoma .i 64 to 691 1 to 628       628/703
(89 %)
16 diff
(97.8 %id)
DA737702   .i 64 to 523 2 to 461   capped   460/835
(55 %)
6 diff
(99.3 %id)
BE262728 brain, neuroblastoma .i 65 to 720 27 to 683       655/683
(95 %)
8 diff
(98.9 %id)
CF128354 Chondrosarcoma Lung Metastasis cell lines, lung .i 65 to 804 1 to 739 exact     739/739
(100 %)
4 diff
(99.5 %id)
TI_154194214   .i 65 to 1003 51 to 978 exact     928/1007
(92 %)
22 diff
(97.9 %id)
N94773 multiple sclerosis lesions .i 66 to 467 1 to 400   fully sequenced,   398/398
(100 %)
20 diff
(95.0 %id)
BF315735 brain, neuroblastoma .i 66 to 844 1 to 777 G62V F63S L65W V66W E67S ...     777/861
(90 %)
24 diff
(97.3 %id)
CF128841 Chondrosarcoma Lung Metastasis cell lines, lung .i 66 to 799 1 to 732 K159T     732/732
(100 %)
6 diff
(99.2 %id)
TI_154188879   .i 66 to 999 44 to 971 K159T AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 928/930
(99 %)
16 diff
(98.3 %id)
BI712883 Pancreas, Purified pancreatic islet .i 69 to 655 7 to 593   fully sequenced,   585/591
(98 %)
6 diff
(99.0 %id)
BU188817 adenocarcinoma, Pancreas .i 69 to 932 1 to 875 H163D     875/927
(94 %)
37 diff
(96.1 %id)
BU185100 adenocarcinoma, Pancreas .i 69 to 927 1 to 866 exact     866/871
(99 %)
15 diff
(98.3 %id)
CN256408 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 73 to 590 1 to 520       520/520
(100 %)
3 diff
(99.5 %id)
CN256414 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i 74 to 687 1 to 616       616/616
(100 %)
2 diff
(99.7 %id)
BE266232 lung, small cell carcinoma .i 74 to 770 1 to 688 L93C L94*     688/715
(96 %)
25 diff
(96.6 %id)
BM721706 eye, fetal eye .i 75 to 590 1 to 516     Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 516/516
(100 %)
0 diff
(100 %id)
BG766107 melanotic melanoma, high MDR (cell line), skin .i 82 to 888 1 to 802 A41R L42S C43A D44T V45W ...     800/802
(99 %)
16 diff
(98.1 %id)
BU191570 epidermoid carcinoma, cell line, salivary gland .i 82 to 843 1 to 765 C135W V153A E155N Q157R G158A ...     765/930
(82 %)
26 diff
(97.3 %id)
BU173466 melanotic melanoma, cell line, skin .i 83 to 904 1 to 831 exact     831/866
(95 %)
12 diff
(98.7 %id)
BU155707 melanotic melanoma, cell line, skin .i 83 to 961 1 to 885 exact     885/918
(96 %)
15 diff
(98.4 %id)
TI_149300764   .i 83 to 1002 960 to 58 G2A S3L T4A W5G G6C ... AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 903/980
(92 %)
27 diff
(97.3 %id)
BE314135 brain, neuroblastoma .i 84 to 738 1 to 648 G62V F63S L65W V66W E67S ...     648/681
(95 %)
11 diff
(98.4 %id)
BG474605 eye, retinoblastoma .i 87 to 849 1 to 765 G158V     765/769
(99 %)
3 diff
(99.7 %id)
CR746477 eye, retinoblastoma .i 93 to 599 12 to 518       505/518
(97 %)
6 diff
(98.9 %id)
CR747566 melanotic melanoma, skin .i 93 to 573 32 to 512       479/512
(93 %)
6 diff
(98.9 %id)
BQ431396 eye, retinoblastoma .i 94 to 932 1 to 845 exact     845/870
(97 %)
10 diff
(98.9 %id)
BE018923 Kidney, renal cell adenocarcinoma .i 95 to 626 1 to 532       532/532
(100 %)
0 diff
(100 %id)
BQ054509 lymph, lymphoma, cell line .i 95 to 976 1 to 888 exact     888/1028
(86 %)
10 diff
(99.1 %id)
BQ062209 lymph, lymphoma, cell line .i 95 to 991 1 to 906 exact     906/1021
(88 %)
16 diff
(98.5 %id)
BQ642205 lymph, lymphoma, cell line .i 95 to 972 1 to 885 exact     885/923
(95 %)
8 diff
(99.2 %id)
DA234215 brain .i 97 to 678 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
CD389114 embryonic trophoblasts, made from WA01 stemcells .i 98 to 949 21 to 883 exact     863/887
(97 %)
26 diff
(97.1 %id)
BF304202 muscle, rhabdomyosarcoma .i 107 to 661 1 to 557       557/557
(100 %)
3 diff
(99.5 %id)
AV687766 hepatocellular carcinoma .i 108 to 555 1 to 446       446/449
(99 %)
3 diff
(99.4 %id)
AV687411 hepatocellular carcinoma .i 108 to 651 1 to 542       542/543
(99 %)
7 diff
(98.8 %id)
BQ673805 epidermoid carcinoma, cell line, salivary gland .i 109 to 971 1 to 877 T138H Y139L A140C I141Y N142Q ...     877/880
(99 %)
30 diff
(96.6 %id)
BQ880981 epidermoid carcinoma, cell line, salivary gland .i 109 to 710 1 to 611       611/1083
(56 %)
23 diff
(97.9 %id)
BF205034 muscle, rhabdomyosarcoma .i 112 to 745 1 to 637 exact     637/1018
(62 %)
4 diff
(99.7 %id)
BM090747 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .i 113 to 631 1 to 519       519/519
(100 %)
0 diff
(100 %id)
BU156444 eye, retinoblastoma .i 113 to 972 1 to 860 exact AAA   860/895
(96 %)
18 diff
(98.0 %id)
BE393296 endometrium, adenocarcinoma cell line, uterus .i 114 to 615 1 to 501       501/502
(99 %)
3 diff
(99.5 %id)
BU526891 epidermoid carcinoma, cell line, lung .i 114 to 882 1 to 776 exact     776/886
(87 %)
11 diff
(98.8 %id)
BE295615 muscle, rhabdomyosarcoma .i 131 to 598 1 to 470       470/470
(100 %)
3 diff
(99.4 %id)
CN256413 embryonic stem cells, DMSO-treated H9 cellline .i 150 to 802 1 to 653 exact     653/653
(100 %)
0 diff
(100 %id)
BG818572 anaplastic oligodendroglioma with 1p/19qloss, brain .i 159 to 960 10 to 874 S3Q T4H W5L S7E P8N ...     721/874
(82 %)
30 diff
(96.6 %id)
BG744330 blood, natural killer cells, cell line .i 160 to 998 1 to 842 exact fully sequenced,   842/842
(100 %)
11 diff
(98.7 %id)
BQ924237 epidermoid carcinoma, cell line, lung .i 161 to 1001 1 to 843 exact     843/930
(90 %)
8 diff
(99.2 %id)
CB126161 Liver .i 163 to 650 1 to 488       488/488
(100 %)
0 diff
(100 %id)
DR003937 Liver .i 167 to 806 11 to 650 exact     638/650
(98 %)
6 diff
(99.1 %id)
BI918488 brain .i 170 to 667 129 to 625       584/625
(93 %)
24 diff
(96.2 %id)
TI_57238604   .i 170 to 667 129 to 625       584/625
(93 %)
24 diff
(96.2 %id)
CN256412 embryonic stem cells, DMSO-treated H9 cellline .i 174 to 920 1 to 747 exact     747/747
(100 %)
1 diff
(99.9 %id)
BU542513 carcinoma, cell line, Prostate .i 175 to 1002 13 to 843 exact AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 831/843
(98 %)
8 diff
(99.1 %id)
BP234279 coronary artery .i 178 to 758 1 to 581 H28P W59R N80S C85W L94I ...     581/581
(100 %)
14 diff
(97.6 %id)
BF204545 muscle, rhabdomyosarcoma .i 181 to 862 1 to 671 W122G I123S L124C F125S F126S ...     671/877
(76 %)
61 diff
(93.1 %id)
BF306972 muscle, rhabdomyosarcoma .i 181 to 999 1 to 808 exact     808/884
(91 %)
28 diff
(96.9 %id)
TI_149300848   .i 185 to 1006 902 to 86 S7A P8L G9P W10G V11C ... AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 817/957
(85 %)
11 diff
(98.9 %id)
BG715417 brain, hypothalamus .i 187 to 998 1 to 813 exact AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 811/813
(99 %)
10 diff
(98.8 %id)
TI_57197565   .i 189 to 879 32 to 715 S7K V11C R12G L13R A14S ...     684/715
(95 %)
12 diff
(98.4 %id)
BF203164 muscle, rhabdomyosarcoma .i 190 to 959 1 to 759 C135V I136S T137P T138P Y139M ...     759/925
(82 %)
22 diff
(97.7 %id)
AA125766 uterus .i 191 to 559 1 to 370       370/373
(99 %)
16 diff
(95.8 %id)
BF525733 brain, glioblastoma with EGFR amplification .i 191 to 878 1 to 681 C16A L17*     681/682
(99 %)
9 diff
(98.7 %id)
DB492650 hypothalamus .i 192 to 651 1 to 460       460/460
(100 %)
1 diff
(99.8 %id)
BG030710 breast, mammary adenocarcinoma, cell line .i 193 to 843 13 to 662 G158A K159R A160L K161R R162G ...     648/662
(97 %)
7 diff
(99.0 %id)
BQ673922 epidermoid carcinoma, cell line, salivary gland .i 193 to 906 1 to 727 exact     727/974
(74 %)
22 diff
(97.8 %id)
BQ669549 epidermoid carcinoma, cell line, salivary gland .i 193 to 789 1 to 596 F150L V153A Q154K E155K Q157H ...     596/964
(61 %)
24 diff
(97.6 %id)
BM686721 eye, optic nerve .i 193 to 799 9 to 615 exact     607/615
(98 %)
6 diff
(99.1 %id)
BC002911 Lung, small cell carcinoma .i 194 to 1002 1 to 809 exact available from MGC, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 809/809
(100 %)
0 diff
(100 %id)
BI819355 pooled brain, lung, testis .i 194 to 879 1 to 679 S7K V11C R12G L13R A14S ...     679/679
(100 %)
16 diff
(97.7 %id)
BE276651 melanotic melanoma, skin .i 195 to 820 1 to 625 G158A K159R A160L K161R R162G ...     625/625
(100 %)
2 diff
(99.7 %id)
BM046051 carcinoma, cell line, Prostate .i 197 to 1001 1 to 810 exact     810/827
(97 %)
8 diff
(99.1 %id)
BM046099 carcinoma, cell line, Prostate .i 197 to 1002 1 to 800 S7E G9W W10L V11G R12A ... AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 800/800
(100 %)
12 diff
(98.5 %id)
CD675956 eye, lens .i 198 to 804 9 to 615 exact     615/615
(100 %)
1 diff
(99.9 %id)
CA949947 Pancreas, Purified pancreatic islet .i 198 to 545 1 to 350   fully sequenced,   350/350
(100 %)
2 diff
(99.5 %id)
BI468425 insulinoma, Pancreas .i 199 to 684 8 to 493       486/493
(98 %)
4 diff
(99.2 %id)
CK903229 insulinoma, Pancreas .i 199 to 675 8 to 484       475/484
(98 %)
6 diff
(98.8 %id)
AL708363 human skeletal muscle .i 203 to 543 1 to 346       344/351
(98 %)
6 diff
(98.3 %id)
BG421538 Kidney, renal cell adenocarcinoma .i 203 to 999 1 to 793 G158A K159R A160L K161R R162G ...     793/889
(89 %)
21 diff
(97.7 %id)
BG120997 adenocarcinoma, cell line, Liver .i 204 to 992 1 to 774 W122G I123S L124C F125S F126S ...     774/914
(84 %)
17 diff
(98.2 %id)
BU541676 carcinoma, cell line, Prostate .i 204 to 998 1 to 795 exact AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 795/795
(100 %)
0 diff
(100 %id)
TI_57176352   .i 204 to 973 23 to 790 G158A K159R A160L K161R R162G ...     768/790
(97 %)
7 diff
(99.2 %id)
BG027046 Bone, osteosarcoma, cell line .i 208 to 853 1 to 651 T138S L145P M146D W147V L148A ...     651/654
(99 %)
10 diff
(98.5 %id)
CA777599 Pancreas, Purified pancreatic islet .i 208 to 612 1 to 407   fully sequenced,   405/405
(100 %)
9 diff
(97.8 %id)
BE910635 epithelioid carcinoma, Pancreas .i 209 to 969 1 to 761 G158D     761/1077
(70 %)
22 diff
(98.0 %id)
BI829787 brain, medulla .i 211 to 973 1 to 762 G158A K159R A160L K161R R162G ...     762/762
(100 %)
1 diff
(99.9 %id)
BE794497 lung, small cell carcinoma .i 215 to 968 1 to 752 exact     752/843
(89 %)
12 diff
(98.6 %id)
CA941577 Pancreas, Purified pancreatic islet .i 218 to 545 1 to 328   fully sequenced,   328/328
(100 %)
0 diff
(100 %id)
BM544275 ovary (pool of 3) .i 219 to 1004 1 to 795 exact     795/1027
(77 %)
17 diff
(98.4 %id)
CN256409 embryonic stem cells, DMSO-treated H9 cellline .i 220 to 942 1 to 725 exact     723/725
(99 %)
4 diff
(99.5 %id)
BG034488 breast, mammary adenocarcinoma, cell line .i 223 to 993 1 to 768 exact AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 768/772
(99 %)
10 diff
(98.8 %id)
BF314688 brain, neuroblastoma .i 225 to 987 1 to 761 exact AAA   761/774
(98 %)
12 diff
(98.5 %id)
TI_149309282   .i 225 to 1002 863 to 88 G2X P8L V11C R12G L13S ... AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 776/1004
(77 %)
12 diff
(98.9 %id)
BG911593 anaplastic oligodendroglioma with 1p/19qloss, brain .i 226 to 999 1 to 782 S7A P8L G9A W10G V11C ...     782/789
(99 %)
28 diff
(96.5 %id)
H94190 liver and spleen .i 228 to 611 1 to 382   fully sequenced,   382/382
(100 %)
8 diff
(98.0 %id)
BP871384 embryonal kidney .i 229 to 560 1 to 332       332/332
(100 %)
1 diff
(99.7 %id)
CA940990 Pancreas, Purified pancreatic islet .i 230 to 680 1 to 451   fully sequenced,   451/451
(100 %)
0 diff
(100 %id)
R47882 breast .i 231 to 612 1 to 391   fully sequenced,   391/391
(100 %)
13 diff
(96.7 %id)
AY423044 Kidney .i 232 to 723 1 to 492 exact     492/492
(100 %)
0 diff
(100 %id)
AY521634   .i 232 to 723 1 to 492 exact     492/492
(100 %)
0 diff
(100 %id)
CV026469 mixed .i 232 to 722 1 to 491       491/589
(83 %)
1 diff
(99.9 %id)
BC000828.
matches multiple genes
cervical carcinoma cell line, cervix, Cervix, carcinoma .i 232 to 1002 1 to 771 exact available from MGC, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base), also hits gene UBE2K 771/771
(100 %)
0 diff
(100 %id)
TI_1948098817   .i 232 to 722 619 to 129       491/1363
(36 %)
6 diff
(99.6 %id)
BE391657 endometrium, adenocarcinoma cell line, uterus .i 233 to 874 38 to 675       636/675
(94 %)
13 diff
(98.1 %id)
BM804037 duodenal adenocarcinoma, cell line, small intestine .i 233 to 906 1 to 685       685/1017
(67 %)
18 diff
(98.3 %id)
CA841270 Pancreas, Purified pancreatic islet .i 233 to 626 1 to 396   fully sequenced,   396/396
(100 %)
2 diff
(99.5 %id)
TI_1948098542   .i 234 to 722 619 to 128       492/1410
(34 %)
20 diff
(98.6 %id)
BE387269 melanotic melanoma, skin .i 236 to 843 34 to 641       608/641
(94 %)
6 diff
(99.1 %id)
BE875593 large cell carcinoma, undifferentiated, lung .i 247 to 985 1 to 730       730/1070
(68 %)
20 diff
(98.2 %id)
BG341894 B-cells, primary B-cells from tonsils (cell line) .i 252 to 1002 1 to 740   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 740/740
(100 %)
14 diff
(98.2 %id)
BM312060 Pancreas, Purified pancreatic islet .i 256 to 820 10 to 574       565/574
(98 %)
6 diff
(99.0 %id)
CA842143 Pancreas, Purified pancreatic islet .i 256 to 690 10 to 444   fully sequenced,   435/444
(97 %)
6 diff
(98.7 %id)
TI_154045136   .i 256 to 998 834 to 91   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 744/992
(75 %)
6 diff
(99.4 %id)
CD370301 Alveolar Macrophage, lung .i 260 to 998 757 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 739/739
(100 %)
2 diff
(99.8 %id)
BM509846 Pancreas, Purified pancreatic islet .i 262 to 729 1 to 468       468/468
(100 %)
0 diff
(100 %id)
AA156956 uterus .i 268 to 666 1 to 389   fully sequenced,   389/389
(100 %)
3 diff
(99.3 %id)
AA478165 ovarian tumor, ovary .i 268 to 671 1 to 397   fully sequenced,   397/397
(100 %)
7 diff
(98.3 %id)
BI195504 brain, neuroblastoma .i 268 to 754 453 to 939       485/1074
(45 %)
41 diff
(96.2 %id)
BI791848 Pancreas, Purified pancreatic islet .i 270 to 761 1 to 492   fully sequenced,   492/492
(100 %)
0 diff
(100 %id)
TI_1948098677   .i 276 to 722 574 to 128       447/1395
(32 %)
7 diff
(99.5 %id)
BU623356 cell lines, Enchondroma .i 280 to 1002 740 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 722/722
(100 %)
5 diff
(99.4 %id)
BQ936762 carcinoma, cell line, Prostate .i 283 to 1002 1 to 721   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 721/721
(100 %)
1 diff
(99.9 %id)
BQ183840 Knee, Osteoarthritic Cartilage .i 290 to 1002 731 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 713/713
(100 %)
3 diff
(99.6 %id)
BU626701 Alveolar Macrophage, lung .i 290 to 1002 730 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 712/714
(99 %)
1 diff
(99.9 %id)
CA308540 Alveolar Macrophage, lung .i 290 to 1002 729 to 16   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 714/714
(100 %)
4 diff
(99.5 %id)
DB476946.
matches multiple genes
hippocampus .i 291 to 798 1 to 508     also hits gene shorspaw 508/508
(100 %)
0 diff
(100 %id)
BQ005999 Chondrosarcoma, Left Pelvis .i 305 to 1002 718 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 700/700
(100 %)
3 diff
(99.6 %id)
BU628056 Bone, Enchondroma cell line .i 311 to 1002 708 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 690/693
(99 %)
4 diff
(99.5 %id)
BM685470 eye, RPE and Choroid .i 313 to 545 1 to 233   fully sequenced, Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 233/233
(100 %)
2 diff
(99.2 %id)
CA841177 Pancreas, Purified pancreatic islet .i 319 to 761 1 to 443   fully sequenced,   443/443
(100 %)
0 diff
(100 %id)
BP306136   .i 319 to 901 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BM312138 Pancreas, Purified pancreatic islet .i 333 to 706 1 to 374       374/374
(100 %)
0 diff
(100 %id)
BU687692 lung .i 345 to 1002 677 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 659/659
(100 %)
5 diff
(99.3 %id)
BQ017093 lung, Metastatic Chondrosarcoma .i 346 to 998 672 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 654/654
(100 %)
1 diff
(99.9 %id)
BG570358 lung .i 348 to 999 1 to 651       651/840
(77 %)
5 diff
(99.5 %id)
BM976838 lung, Primary Lung Cystic Fibrosis EpithelialCells .i 359 to 1006 665 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 647/647
(100 %)
3 diff
(99.6 %id)
BM976770 lung, Primary Lung Cystic Fibrosis EpithelialCells .i 359 to 1002 662 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 644/644
(100 %)
2 diff
(99.7 %id)
CA411995 Chondrosarcoma Grade II, Left Pelvis .i 359 to 998 659 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 641/641
(100 %)
2 diff
(99.7 %id)
CA423003 cell lines, Chondrosarcoma .i 359 to 1002 661 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 643/643
(100 %)
1 diff
(99.9 %id)
BM545980 ovary (pool of 3) .i 379 to 1002 1 to 624       624/624
(100 %)
1 diff
(99.9 %id)
CA749043 cell lines, Chondrosarcoma .i 380 to 998 638 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 620/620
(100 %)
2 diff
(99.7 %id)
CA310469 cell lines, Chondrosarcoma .i 380 to 1002 642 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 624/624
(100 %)
3 diff
(99.6 %id)
BQ774289 Chondrosarcoma Grade II, Left Pelvis .i 381 to 1002 643 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 625/625
(100 %)
3 diff
(99.6 %id)
BQ637491 eye, retina .i 388 to 1002 1 to 615   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 615/615
(100 %)
0 diff
(100 %id)
BU628619 Bone, Enchondroma cell line .i 395 to 1002 626 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 608/608
(100 %)
1 diff
(99.9 %id)
CA309901 Alveolar Macrophage, lung .i 395 to 1002 626 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 608/608
(100 %)
1 diff
(99.9 %id)
CA414718 Chondrosarcoma Grade II, Left Pelvis .i 401 to 1002 620 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 602/604
(99 %)
15 diff
(97.6 %id)
CD367722 Alveolar Macrophage, lung .i 401 to 1002 615 to 15   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 601/602
(99 %)
9 diff
(98.6 %id)
BQ021631 lung, Metastatic Chondrosarcoma .i 402 to 1002 619 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 601/601
(100 %)
2 diff
(99.7 %id)
CA421927 Bone, Enchondroma cell line .i 405 to 1002 618 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 600/600
(100 %)
3 diff
(99.5 %id)
BQ772061 Chondrosarcoma Grade II, Left Pelvis .i 409 to 1002 612 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 594/594
(100 %)
1 diff
(99.9 %id)
AA398056.
matches multiple genes
  .i 416 to 799 1 to 385     also hits gene ZFPL1 385/388
(99 %)
2 diff
(99.5 %id)
BF889167 testis_normal .i 421 to 823 1 to 401       401/401
(100 %)
9 diff
(97.8 %id)
W72049 heart .i 422 to 1002 580 to 1       580/593
(97 %)
6 diff
(99.0 %id)
CA771055 Pancreas, Purified pancreatic islet .i 423 to 1001 580 to 1       580/580
(100 %)
1 diff
(99.9 %id)
BP432110   .i 429 to 790 1 to 363       363/363
(100 %)
5 diff
(98.7 %id)
BE140096 Liver .i 432 to 802 1 to 371       371/371
(100 %)
0 diff
(100 %id)
AA643840 normal prostate, Prostate .i 433 to 1002 593 to 22   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 572/572
(100 %)
3 diff
(99.5 %id)
N63475 multiple sclerosis lesions .i 437 to 1000 562 to 1   fully sequenced,   562/562
(100 %)
5 diff
(99.2 %id)
BG939442 bone marrow stroma .i 438 to 1002 595 to 31   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 565/565
(100 %)
7 diff
(98.8 %id)
AW800090 uterus .i 442 to 870 13 to 441       429/451
(95 %)
12 diff
(97.4 %id)
BG767814 melanotic melanoma, high MDR (cell line), skin .i 442 to 1002 1 to 561   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 561/561
(100 %)
1 diff
(99.9 %id)
BG744899 blood, natural killer cells, cell line .i 445 to 954 513 to 3   fully sequenced,   511/513
(99 %)
0 diff
(100 %id)
AI808064 pooled .i 450 to 1002 553 to 1       553/553
(100 %)
19 diff
(96.6 %id)
BF195525 fibrotheoma, ovary .i 450 to 1002 553 to 1       553/553
(100 %)
1 diff
(99.9 %id)
BP395672 pancreatic islet .i 452 to 1003 1 to 553     Submitted on the opposite strand 553/556
(99 %)
7 diff
(98.8 %id)
AI832232 colon, colon tumor, RER+ .i 459 to 1001 543 to 1       543/543
(100 %)
1 diff
(99.9 %id)
BF058723 fibrotheoma, ovary .i 459 to 1002 544 to 1       544/544
(100 %)
2 diff
(99.7 %id)
AI869318 anaplastic oligodendroglioma, brain .i 461 to 1002 542 to 1       542/542
(100 %)
0 diff
(100 %id)
CB133114 Liver .i 462 to 900 1 to 439       439/439
(100 %)
0 diff
(100 %id)
AI765058 Kidney .i 467 to 1002 536 to 1       536/536
(100 %)
4 diff
(99.3 %id)
BM663008 eye, RPE and Choroid .i 484 to 1013 546 to 18   fully sequenced, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 529/529
(100 %)
1 diff
(99.9 %id)
AA034035 liver and spleen .i 485 to 1002 519 to 1       519/519
(100 %)
4 diff
(99.3 %id)
AW026472 brain, glioblastoma (pooled) .i 494 to 998 505 to 1       505/505
(100 %)
0 diff
(100 %id)
CA943515 Pancreas, Purified pancreatic islet .i 494 to 1001 508 to 1   fully sequenced,   508/508
(100 %)
0 diff
(100 %id)
CA943761 Pancreas, Purified pancreatic islet .i 494 to 1001 508 to 1   fully sequenced,   508/508
(100 %)
0 diff
(100 %id)
CA950830 Pancreas, Purified pancreatic islet .i 494 to 1002 509 to 1   fully sequenced,   509/509
(100 %)
0 diff
(100 %id)
CA308928 Alveolar Macrophage, lung .i 494 to 1002 527 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 509/509
(100 %)
3 diff
(99.5 %id)
CA941284 Pancreas, Purified pancreatic islet .i 496 to 1003 510 to 3   fully sequenced,   508/510
(99 %)
0 diff
(100 %id)
BM690961 eye, RPE and Choroid .i 497 to 1013 1 to 517   fully sequenced, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 517/517
(100 %)
4 diff
(99.3 %id)
CA312188 Human Lung Epithelial cells, lung .i 500 to 1002 521 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 503/503
(100 %)
11 diff
(97.9 %id)
BU728331 eye, eye anterior segment .i 500 to 1002 521 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 503/503
(100 %)
1 diff
(99.9 %id)
BP397771 pancreatic islet .i 504 to 1002 1 to 500     Submitted on the opposite strand 500/500
(100 %)
1 diff
(99.8 %id)
BP371557 testis .i 508 to 1006 1 to 499   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 499/499
(100 %)
0 diff
(100 %id)
DB370312   .i 513 to 1002 491 to 1       491/576
(85 %)
2 diff
(99.7 %id)
R47883 breast .i 582 to 998 421 to 1   fully sequenced,   421/421
(100 %)
6 diff
(98.6 %id)
CA777346 Pancreas, Purified pancreatic islet .i 582 to 1002 421 to 1   fully sequenced,   421/421
(100 %)
0 diff
(100 %id)
CA841009 Pancreas, Purified pancreatic islet .i 596 to 1012 417 to 1   fully sequenced,   417/417
(100 %)
0 diff
(100 %id)
H94295 liver and spleen .i 602 to 1002 402 to 1   fully sequenced,   402/402
(100 %)
1 diff
(99.8 %id)
BI791474 Pancreas, Purified pancreatic islet .i 625 to 1005 382 to 1   fully sequenced,   382/382
(100 %)
3 diff
(99.3 %id)
W94777 heart .i 629 to 1002 381 to 1       381/381
(100 %)
7 diff
(98.2 %id)
AA156864 uterus .i 636 to 1002 370 to 1   fully sequenced,   370/370
(100 %)
1 diff
(99.8 %id)
BM677297 eye, fetal eye .i 649 to 1002 368 to 15   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 354/354
(100 %)
3 diff
(99.2 %id)
CA866013 Pancreas, Purified pancreatic islet .i 650 to 1001 352 to 1   fully sequenced,   352/352
(100 %)
0 diff
(100 %id)
AA478010 ovarian tumor, ovary .i 653 to 1002 350 to 1   fully sequenced,   350/350
(100 %)
1 diff
(99.8 %id)
AA127044 uterus .i 655 to 1003 351 to 2       350/424
(82 %)
0 diff
(100 %id)
CA841848 Pancreas, Purified pancreatic islet .i 660 to 1002 343 to 1   fully sequenced,   343/343
(100 %)
0 diff
(100 %id)
BI713605 Pancreas, Purified pancreatic islet .i 731 to 1012 282 to 1   fully sequenced,   282/282
(100 %)
4 diff
(98.6 %id)
CA840921 Pancreas, Purified pancreatic islet .i 731 to 1006 276 to 1   fully sequenced,   276/276
(100 %)
3 diff
(99.0 %id)
BU726291 eye, RPE and Choroid .i 770 to 1013 261 to 18   fully sequenced, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 244/244
(100 %)
1 diff
(99.6 %id)
AF176924 normal aorta .j 1 to 1064 1 to 1065 exact tiling clone, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 1065/1065
(100 %)
2 diff
(99.9 %id)
BF081714 amnion_normal .j 564 to 926 370 to 11       360/370
(97 %)
0 diff
(100 %id)
BF792430 adrenal cortex carcinoma, cell line, adrenal gland .k 1 to 793 1 to 783 R84G A85L G86V G87E A88H ... tiling clone,   783/962
(81 %)
21 diff
(97.9 %id)
AA044694 uterus .k 18 to 496 1 to 475 C43X D44T V45W G46A T47P ...     475/475
(100 %)
4 diff
(99.2 %id)
BU595513 mixed (pool of 40 RNAs) .k 22 to 765 1 to 748   tiling clone,   748/749
(99 %)
11 diff
(98.6 %id)
BG324733 Kidney, renal cell adenocarcinoma .k 31 to 518 1 to 491 T111Y A112K I113L V114L R115L ...     491/516
(95 %)
9 diff
(98.3 %id)
BE928658 denis_drash .k 152 to 713 1 to 579       579/584
(99 %)
38 diff
(93.5 %id)
TI_151809324   .l 1 to 643 79 to 722 G71X P96L W113X A115G A116S ... tiling clone,   644/648
(99 %)
6 diff
(99.1 %id)
BM699427 eye, fetal eyes .m 1 to 331 1 to 331   tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 331/331
(100 %)
0 diff
(100 %id)
BM670074 eye, fetal eyes .m 270 to 788 537 to 19   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 519/519
(100 %)
0 diff
(100 %id)
DA507201 brain .n 1 to 498 2 to 499 A26V L79P tiling clone, capped   498/498
(100 %)
2 diff
(99.6 %id)
BP274367 Kidney .n 9 to 371 1 to 364       364/568
(64 %)
13 diff
(97.8 %id)
AA045652 uterus .n 61 to 262 1 to 201       201/201
(100 %)
4 diff
(98.1 %id)
DW445941 Liver .n 125 to 335 9 to 219   tiling clone,   211/219
(96 %)
6 diff
(97.3 %id)
AA297475 endometrium .n 153 to 291 1 to 139       139/139
(100 %)
0 diff
(100 %id)
AI269986 esophagus, squamous cell carcinoma .n 157 to 311 1 to 155     Submitted on the opposite strand 155/155
(100 %)
0 diff
(100 %id)
T24460   .n 199 to 328 1 to 127       127/127
(100 %)
3 diff
(97.7 %id)
DA485884 brain .o 1 to 473 52 to 524   tiling clone, capped   473/517
(91 %)
6 diff
(98.9 %id)
BF982559 duodenal adenocarcinoma, cell line, small intestine .o 23 to 778 1 to 750 P83L     750/751
(99 %)
14 diff
(98.2 %id)
NM_206824.1   .o 24 to 910 1 to 887 exact RefSeq, AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 887/887
(100 %)
0 diff
(100 %id)
BM557143 amelanotic melanoma, cell line, skin .o 51 to 910 1 to 861 exact AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 861/861
(100 %)
6 diff
(99.4 %id)
BM554351 amelanotic melanoma, cell line, skin .o 51 to 721 1 to 675 exact     675/1103
(61 %)
28 diff
(97.5 %id)
AK289790 brain .o 81 to 716 1 to 636 exact     636/636
(100 %)
0 diff
(100 %id)
AA041425 heart .o 81 to 529 1 to 456 W10S V11G R12A L13A A14R ... fully sequenced,   454/454
(100 %)
27 diff
(94.1 %id)
DA230492 brain .o 82 to 716 2 to 636 exact capped   635/635
(100 %)
0 diff
(100 %id)
AA041429 heart .o 82 to 428 1 to 345       345/351
(98 %)
17 diff
(95.2 %id)
BQ689511 ductal carcinoma, cell line, Pancreas .o 83 to 906 1 to 828 exact AAA   828/833
(99 %)
11 diff
(98.7 %id)
BF340441 brain, glioblastoma with EGFR amplification .o 96 to 870 13 to 783 exact     771/1040
(74 %)
34 diff
(96.8 %id)
BM560750 eye, retinoblastoma .o 96 to 823 1 to 736 exact     736/1101
(66 %)
21 diff
(98.1 %id)
N24466 melanocyte .o 104 to 545 1 to 434 R33A A34P R35X D38I L42S ... fully sequenced,   434/434
(100 %)
17 diff
(96.1 %id)
CD048319 embryonic stem cells, WA01, passage 38 .o 108 to 906 21 to 820 S50I     800/887
(90 %)
6 diff
(99.4 %id)
AW404352 lymph .o 111 to 515 1 to 405       405/405
(100 %)
5 diff
(98.8 %id)
TI_154141303   .o 118 to 612 81 to 575 exact     495/495
(100 %)
5 diff
(99.0 %id)
BM007613 Spleen .o 128 to 916 1 to 788 P83L     788/816
(96 %)
12 diff
(98.6 %id)
BM007549 Spleen .o 128 to 894 1 to 792 G2M S3G T4S W5T G6C ...     792/883
(89 %)
47 diff
(94.7 %id)
TI_59382780   .o 129 to 894 59 to 849 G2M S3G T4S W5T G6C ...     791/882
(89 %)
46 diff
(94.8 %id)
TI_59382845   .o 129 to 916 63 to 849 P83L     787/815
(96 %)
11 diff
(98.7 %id)
TI_154100715   .o 133 to 906 860 to 83 R58S L59Y P60C A61* AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 778/821
(94 %)
20 diff
(97.6 %id)
CR623242 Placenta Cot 25-normalized .o 138 to 908 1 to 771 exact     771/771
(100 %)
0 diff
(100 %id)
BX396175 Placenta Cot 25-normalized .o 138 to 908 1 to 771 exact     771/771
(100 %)
0 diff
(100 %id)
AK129513 dermoid tumor .o 182 to 910 1 to 729 exact tiling clone, available from FLJ,   729/729
(100 %)
1 diff
(99.9 %id)
BP227960   .o 182 to 711 1 to 530 exact     530/579
(91 %)
19 diff
(96.8 %id)
BQ950337 large cell carcinoma, lung .o 194 to 910 1 to 718 exact AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 718/718
(100 %)
2 diff
(99.8 %id)
CD175426 embryonic stem cells, WA01, passage 38 .o 196 to 910 19 to 736 exact AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 718/736
(97 %)
15 diff
(98.0 %id)
CD249837 embryonic stem cells, WA01, passage 38 .o 196 to 910 18 to 734 exact AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 717/734
(97 %)
10 diff
(98.7 %id)
BM471717 melanotic melanoma, skin .o 206 to 778 1 to 574 exact     574/1160
(49 %)
11 diff
(99.1 %id)
BX351436.
matches multiple genes
Placenta Cot 25-normalized .o 207 to 897 691 to 1 T4N G9A C16S V21G L22F ...   also hits gene CERCAM 691/763
(90 %)
25 diff
(96.8 %id)
AW839917 leiomios .o 222 to 711 492 to 2 T47H A48R I49H S50Q C51L ...     491/495
(99 %)
3 diff
(99.4 %id)
BU600828 mixed (pool of 40 RNAs) .o 229 to 908 1 to 682 exact     682/841
(81 %)
15 diff
(98.3 %id)
H81366 liver and spleen .o 244 to 545 1 to 300 A34P R35G D36P R37G D38L ... fully sequenced,   300/300
(100 %)
5 diff
(98.4 %id)
TI_59392256   .o 251 to 910 82 to 738   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 657/657
(100 %)
4 diff
(99.4 %id)
BM014263 breast, mammary adenocarcinoma, cell line .o 252 to 910 1 to 656   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 656/656
(100 %)
4 diff
(99.4 %id)
BU950107 Pancreas, Purified pancreatic islet .o 252 to 777 10 to 535   fully sequenced,   526/535
(98 %)
6 diff
(98.9 %id)
DW416597 Liver .o 284 to 591 1 to 308       308/308
(100 %)
0 diff
(100 %id)
AA205661   .o 298 to 909 605 to 1       605/609
(99 %)
20 diff
(96.8 %id)
CA771835 Pancreas, Purified pancreatic islet .o 298 to 908 614 to 4       611/614
(99 %)
0 diff
(100 %id)
BM737748 Ascites, stomach .o 310 to 921 1 to 612   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 612/612
(100 %)
6 diff
(99.1 %id)
CA441511 Fibrosarcoma .o 377 to 906 560 to 19   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 542/542
(100 %)
8 diff
(98.6 %id)
AW248507 lung, small cell carcinoma .o 394 to 907 538 to 14   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 525/528
(99 %)
2 diff
(99.7 %id)
AW079287 colon, juvenile granulosa tumor .o 414 to 910 494 to 1       494/518
(95 %)
22 diff
(95.8 %id)
BG201728   .o 417 to 912 1 to 491   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 491/491
(100 %)
8 diff
(98.4 %id)
BG221002   .o 417 to 917 1 to 499       499/858
(58 %)
10 diff
(98.9 %id)
BI160049 epithelioid carcinoma cell line, Pancreas .o 417 to 912 210 to 731       522/731
(71 %)
19 diff
(97.5 %id)
BG193053   .o 418 to 914 1 to 497       497/497
(100 %)
3 diff
(99.4 %id)
BG201215   .o 418 to 910 1 to 493   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 493/493
(100 %)
10 diff
(98.0 %id)
BG196598   .o 421 to 724 1 to 305       305/305
(100 %)
8 diff
(97.4 %id)
BG202794   .o 421 to 910 507 to 18   AAA Submitted on the opposite strand 490/716
(68 %)
14 diff
(98.1 %id)
AI277854 placenta .o 421 to 911 493 to 3       491/530
(92 %)
0 diff
(100 %id)
BQ268808 Pancreas, Purified pancreatic islet .o 421 to 910 491 to 1       491/495
(99 %)
1 diff
(99.8 %id)
AI127262 heart .o 430 to 911 484 to 3       482/484
(99 %)
0 diff
(100 %id)
AI884693 anaplastic oligodendroglioma, brain .o 430 to 910 481 to 1       481/481
(100 %)
0 diff
(100 %id)
BF061732 pooled germ cell tumors .o 430 to 899 470 to 1       470/470
(100 %)
1 diff
(99.8 %id)
AW872762 squamous cell carcinoma, tongue .o 431 to 910 480 to 1       480/480
(100 %)
0 diff
(100 %id)
AI376148   .o 432 to 908 478 to 2       477/478
(99 %)
0 diff
(100 %id)
AA146971 uterus .o 433 to 910 480 to 2       479/484
(98 %)
0 diff
(100 %id)
AI765029 Kidney .o 433 to 910 478 to 1       478/478
(100 %)
2 diff
(99.6 %id)
AI073710 senescent fibroblast .o 435 to 914 492 to 14   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 479/479
(100 %)
2 diff
(99.6 %id)
AI955852 adenocarcinoma, Pancreas .o 435 to 910 492 to 16   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 477/477
(100 %)
5 diff
(99.0 %id)
CA309365 Alveolar Macrophage, lung .o 438 to 910 489 to 17   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 473/618
(76 %)
1 diff
(99.9 %id)
W46277 senescent fibroblast .o 439 to 910 488 to 12   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 477/477
(100 %)
8 diff
(98.4 %id)
AW024138 Kidney .o 439 to 910 472 to 1       472/472
(100 %)
1 diff
(99.8 %id)
BG610782 adenocarcinoma, Prostate .o 441 to 916 1 to 479   AAA   479/499
(95 %)
8 diff
(98.4 %id)
AW439832 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .o 442 to 910 469 to 1       469/469
(100 %)
0 diff
(100 %id)
BG222313 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .o 442 to 911 469 to 1       469/469
(100 %)
6 diff
(98.8 %id)
AA708126 pineal gland .o 443 to 911 469 to 1       469/469
(100 %)
0 diff
(100 %id)
AA813521   .o 445 to 911 469 to 3       467/469
(99 %)
0 diff
(100 %id)
AI339947   .o 445 to 913 472 to 4       469/472
(99 %)
0 diff
(100 %id)
AI589714 anaplastic oligodendroglioma, brain .o 445 to 910 466 to 1       466/466
(100 %)
1 diff
(99.8 %id)
AI498928 anaplastic oligodendroglioma, brain .o 445 to 910 466 to 1       466/466
(100 %)
1 diff
(99.8 %id)
AI123913 heart .o 446 to 910 465 to 1       465/465
(100 %)
0 diff
(100 %id)
BF435947 pooled .o 446 to 897 453 to 2       452/453
(99 %)
0 diff
(100 %id)
CK903228 insulinoma, Pancreas .o 447 to 916 471 to 2       470/471
(99 %)
0 diff
(100 %id)
DB563718 hypothalamus .o 448 to 906 1 to 460     Submitted on the opposite strand 460/460
(100 %)
11 diff
(97.7 %id)
AI147240 uterus .o 448 to 910 474 to 12   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 463/463
(100 %)
3 diff
(99.4 %id)
AI694928 carcinoid, lung .o 448 to 910 473 to 12   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 462/462
(100 %)
2 diff
(99.6 %id)
AW242703 Kidney .o 448 to 916 472 to 3       470/472
(99 %)
0 diff
(100 %id)
W79426 heart .o 449 to 911 466 to 1       466/466
(100 %)
4 diff
(99.2 %id)
AA553820 colon, tumor .o 450 to 910 488 to 28   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 461/461
(100 %)
0 diff
(100 %id)
AI301956 2 pooled tumors (clear cell type), Kidney .o 450 to 911 465 to 4       462/465
(99 %)
0 diff
(100 %id)
AA296786 aorta .o 452 to 726 1 to 275       275/275
(100 %)
0 diff
(100 %id)
AI268993 Kidney .o 452 to 910 459 to 1       459/459
(100 %)
2 diff
(99.6 %id)
AI304651 adenocarcinoma, colon .o 457 to 910 454 to 1       454/454
(100 %)
1 diff
(99.8 %id)
AI347608 2 pooled tumors (clear cell type), Kidney .o 457 to 923 473 to 7       467/473
(98 %)
0 diff
(100 %id)
AI311112 2 pooled tumors (clear cell type), Kidney .o 458 to 911 456 to 3       454/456
(99 %)
0 diff
(100 %id)
AI075899   .o 462 to 911 452 to 3       450/452
(99 %)
0 diff
(100 %id)
BF195494 carcinoid, lung .o 462 to 911 452 to 3       450/452
(99 %)
0 diff
(100 %id)
BE833225 ovary .o 466 to 771 310 to 5       306/310
(98 %)
0 diff
(100 %id)
AI346935 adenocarcinoma, colon .o 466 to 910 445 to 1       445/445
(100 %)
1 diff
(99.8 %id)
TI_151740675   .o 468 to 916 560 to 103       458/561
(81 %)
47 diff
(91.7 %id)
BE669425 carcinoid, lung .o 471 to 911 445 to 5       441/445
(99 %)
0 diff
(100 %id)
AI560747 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .o 472 to 916 447 to 3       445/447
(99 %)
0 diff
(100 %id)
BM313349 Pancreas, Purified pancreatic islet .o 475 to 909 435 to 1       435/435
(100 %)
0 diff
(100 %id)
AA781466   .o 483 to 911 431 to 3       429/431
(99 %)
0 diff
(100 %id)
AI342962 carcinoid, lung .o 483 to 909 427 to 1       427/427
(100 %)
0 diff
(100 %id)
N23743 melanocyte .o 484 to 910 430 to 1       430/430
(100 %)
3 diff
(99.4 %id)
AA625788   .o 485 to 915 433 to 3       431/433
(99 %)
0 diff
(100 %id)
BM311539 Pancreas, Purified pancreatic islet .o 490 to 920 431 to 1       431/431
(100 %)
0 diff
(100 %id)
AI090370 senescent fibroblast .o 490 to 910 432 to 12   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 421/421
(100 %)
5 diff
(98.9 %id)
BM090962 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .o 492 to 911 421 to 2       420/421
(99 %)
0 diff
(100 %id)
AI338271 lung .o 494 to 916 426 to 3       424/426
(99 %)
0 diff
(100 %id)
BU537827 mixed (pool of 40 RNAs) .o 502 to 906 1 to 405       405/440
(92 %)
2 diff
(99.6 %id)
AA041385 heart .o 505 to 910 406 to 1   fully sequenced,   406/406
(100 %)
2 diff
(99.6 %id)
N35718 melanocyte .o 506 to 910 408 to 1       408/409
(99 %)
3 diff
(99.3 %id)
AA041191 heart .o 506 to 911 413 to 5       409/413
(99 %)
0 diff
(100 %id)
AA399114.
matches multiple genes
  .o 506 to 911 409 to 3     This clone was ignored, also hits gene ZFPL1 407/409
(99 %)
0 diff
(100 %id)
AI969210 lung, two pooled squamous cell carcinomas .o 507 to 911 407 to 3       405/407
(99 %)
0 diff
(100 %id)
AW136724   .o 510 to 910 418 to 18   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 401/401
(100 %)
0 diff
(100 %id)
H81310 liver and spleen .o 515 to 910 408 to 1   fully sequenced,   408/408
(100 %)
10 diff
(97.6 %id)
H99183 melanocyte .o 515 to 910 402 to 1   fully sequenced,   402/402
(100 %)
3 diff
(99.3 %id)
AA770182   .o 520 to 911 394 to 3       392/394
(99 %)
0 diff
(100 %id)
AA836303 germinal center B cell .o 521 to 910 425 to 36   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 390/390
(100 %)
0 diff
(100 %id)
AA741397 2 pooled tumors (clear cell type), Kidney .o 525 to 911 391 to 5       387/391
(98 %)
0 diff
(100 %id)
AA709462 pineal gland .o 528 to 910 406 to 24   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 383/383
(100 %)
1 diff
(99.8 %id)
N30038.
matches multiple genes
placenta .o 530 to 910 407 to 24   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base), also hits gene VKORC1P1 384/384
(100 %)
3 diff
(99.3 %id)
AA974145 pooled germ cell tumors .o 530 to 911 383 to 2       382/383
(99 %)
0 diff
(100 %id)
AI597845 Prostate .o 534 to 907 374 to 1       374/374
(100 %)
6 diff
(98.4 %id)
AA707176 liver and spleen .o 536 to 882 347 to 1       347/347
(100 %)
1 diff
(99.8 %id)
AA935742 2 pooled tumors (clear cell type), Kidney .o 537 to 826 290 to 1       290/290
(100 %)
1 diff
(99.7 %id)
AI686517 Prostate .o 542 to 910 369 to 1       369/369
(100 %)
3 diff
(99.2 %id)
AA298982 Bone .o 543 to 891 1 to 350       350/350
(100 %)
2 diff
(99.5 %id)
AA708782 uterus .o 543 to 906 364 to 1       364/364
(100 %)
1 diff
(99.8 %id)
AA513969 alveolar rhabdomyosarcoma .o 544 to 911 1 to 367       367/376
(97 %)
8 diff
(97.9 %id)
AA704970 liver and spleen .o 545 to 906 362 to 1       362/362
(100 %)
1 diff
(99.8 %id)
CU450005 epidermis .o 548 to 689 84 to 225       142/225
(63 %)
6 diff
(97.4 %id)
AI423158 brain, glioblastoma (pooled) .o 552 to 908 360 to 4       357/360
(99 %)
0 diff
(100 %id)
BU943756 mixed (pool of 40 RNAs) .o 552 to 911 1 to 361   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 361/364
(99 %)
4 diff
(99.0 %id)
AI038344 senescent fibroblast .o 553 to 913 364 to 4       361/364
(99 %)
0 diff
(100 %id)
BG152852 Prostate .o 553 to 911 360 to 2       359/360
(99 %)
0 diff
(100 %id)
AI291572 placenta .o 554 to 911 359 to 3       357/359
(99 %)
0 diff
(100 %id)
AA468439   .o 555 to 911 1 to 357       357/357
(100 %)
5 diff
(98.6 %id)
AI374736   .o 555 to 911 359 to 3       357/359
(99 %)
0 diff
(100 %id)
AI497678 anaplastic oligodendroglioma, brain .o 556 to 910 366 to 12   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 355/355
(100 %)
5 diff
(98.6 %id)
AA868201   .o 558 to 911 356 to 3       354/356
(99 %)
0 diff
(100 %id)
AW968213   .o 560 to 910 74 to 424       351/586
(59 %)
1 diff
(99.9 %id)
AA468399   .o 560 to 908 369 to 21   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 349/356
(98 %)
0 diff
(100 %id)
R06215 liver and spleen .o 566 to 901 336 to 1       336/336
(100 %)
3 diff
(99.2 %id)
AW204374   .o 573 to 906 351 to 18   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 334/334
(100 %)
0 diff
(100 %id)
AI219428 placenta .o 574 to 916 345 to 3       343/345
(99 %)
0 diff
(100 %id)
BP395163 pancreatic islet .o 575 to 881 1 to 306     Submitted on the opposite strand 306/306
(100 %)
2 diff
(99.4 %id)
AA025410 heart .o 575 to 910 340 to 1       340/340
(100 %)
4 diff
(98.9 %id)
CD631829   .o 576 to 885 316 to 6       311/323
(96 %)
0 diff
(100 %id)
CD631830   .o 576 to 885 8 to 317       310/323
(95 %)
10 diff
(97.0 %id)
F30226 pectoral muscle (after mastectomy) .o 577 to 702 1 to 126       126/126
(100 %)
3 diff
(97.7 %id)
AW243034 Kidney .o 578 to 910 333 to 1       333/333
(100 %)
0 diff
(100 %id)
AI203479   .o 580 to 911 336 to 5       332/336
(98 %)
0 diff
(100 %id)
AI341986 pooled germ cell tumors .o 582 to 910 366 to 38   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 329/329
(100 %)
19 diff
(94.3 %id)
AA970265 Kidney, kidney tumor .o 588 to 870 284 to 1       284/284
(100 %)
3 diff
(99.0 %id)
AA704288 liver and spleen .o 591 to 910 320 to 1       320/320
(100 %)
2 diff
(99.4 %id)
AA991336 breast .o 593 to 909 317 to 1       317/317
(100 %)
0 diff
(100 %id)
AA993215   .o 593 to 910 330 to 13   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 318/318
(100 %)
4 diff
(98.8 %id)
AA745913 Kidney .o 595 to 910 316 to 1       316/316
(100 %)
0 diff
(100 %id)
AW000874 colon, colonic mucosa from 3 patients with Crohn'sdisease .o 601 to 908 314 to 5       310/322
(96 %)
0 diff
(100 %id)
BE645626 Prostate .o 604 to 908 306 to 1       306/306
(100 %)
4 diff
(98.7 %id)
F27351 pectoral muscle (after mastectomy) .o 610 to 910 1 to 301       301/302
(99 %)
6 diff
(98.1 %id)
AI379942 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .o 612 to 908 304 to 8       297/304
(97 %)
0 diff
(100 %id)
AW204258   .o 615 to 906 309 to 18   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 292/299
(97 %)
1 diff
(99.7 %id)
H45882 brain .o 618 to 998 1 to 387   tiling clone,   387/388
(99 %)
14 diff
(96.4 %id)
BG697174 skin .o 622 to 910 1 to 289   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 289/289
(100 %)
0 diff
(100 %id)
AV708035 adrenal gland .o 623 to 910 1 to 288   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 288/288
(100 %)
0 diff
(100 %id)
AI761938 Kidney .o 632 to 910 279 to 1       279/279
(100 %)
5 diff
(98.3 %id)
AA542901 normal prostate, Prostate .o 634 to 911 280 to 3       278/280
(99 %)
0 diff
(100 %id)
AA564888 normal prostate, Prostate .o 635 to 911 280 to 4       277/280
(98 %)
0 diff
(100 %id)
AA564958 normal prostate, Prostate .o 635 to 911 280 to 3       278/280
(99 %)
0 diff
(100 %id)
AI357554 ovary, tumor, 5 pooled (see description) .o 636 to 903 300 to 33   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 268/271
(98 %)
0 diff
(100 %id)
AI357603 ovary, tumor, 5 pooled (see description) .o 636 to 898 300 to 38   AAA   263/271
(97 %)
0 diff
(100 %id)
F30350 pectoral muscle (after mastectomy) .o 642 to 911 1 to 270       270/270
(100 %)
0 diff
(100 %id)
AI869708 anaplastic oligodendroglioma, brain .o 647 to 910 264 to 1       264/264
(100 %)
0 diff
(100 %id)
AW235465 pooled germ cell tumors .o 647 to 911 268 to 2       267/268
(99 %)
0 diff
(100 %id)
AI220792 placenta .o 648 to 911 264 to 1       264/264
(100 %)
0 diff
(100 %id)
AI762149 Kidney .o 649 to 916 275 to 8       268/275
(97 %)
0 diff
(100 %id)
BF591489 brain, glioblastoma (pooled) .o 653 to 906 255 to 1       255/255
(100 %)
3 diff
(98.9 %id)
AI956005 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .o 660 to 910 252 to 1       252/252
(100 %)
3 diff
(98.9 %id)
AI919010 Prostate .o 662 to 910 249 to 1       249/249
(100 %)
0 diff
(100 %id)
AW188811 colon, moderately differentiated adenocarcinoma .o 662 to 911 252 to 3       250/252
(99 %)
0 diff
(100 %id)
AW090329 brain, tumor, 5 pooled (see description) .o 663 to 910 248 to 1       248/248
(100 %)
1 diff
(99.6 %id)
AA298368 pineal body .o 668 to 910 243 to 1       243/243
(100 %)
1 diff
(99.6 %id)
AA298370 pineal body .o 668 to 910 1 to 244       244/244
(100 %)
2 diff
(99.2 %id)
AI749204 colon .o 682 to 908 228 to 2       227/229
(99 %)
0 diff
(100 %id)
AI867544 Prostate .o 684 to 908 228 to 4       225/228
(98 %)
0 diff
(100 %id)
AA296693 aorta .o 697 to 921 1 to 225   tiling clone,   225/225
(100 %)
0 diff
(100 %id)
BU752777 placenta .o 714 to 910 214 to 18   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 197/198
(99 %)
6 diff
(97.0 %id)
AA029123 uterus .o 725 to 906 183 to 1       183/186
(98 %)
2 diff
(99.0 %id)
AI369692 anaplastic oligodendroglioma, brain .o 729 to 910 182 to 1       182/182
(100 %)
0 diff
(100 %id)
AI365332 pooled germ cell tumors .o 737 to 910 174 to 1       174/174
(100 %)
1 diff
(99.5 %id)
BM852721 stomach .o 741 to 858 1 to 118       118/118
(100 %)
0 diff
(100 %id)
AA918262 adenocarcinoma, colon .o 744 to 910 167 to 1       167/167
(100 %)
3 diff
(98.3 %id)
BU949793 Pancreas, Purified pancreatic islet .o 747 to 909 163 to 1   fully sequenced,   163/163
(100 %)
1 diff
(99.4 %id)
AA846379   .o 753 to 911 161 to 3       159/161
(98 %)
0 diff
(100 %id)
AI566992 serous papillary carcinoma, high grade, 2pooled tumors, uterus .o 762 to 910 170 to 22   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 149/149
(100 %)
4 diff
(97.4 %id)
AI915437 ovary, tumor, 5 pooled (see description) .o 763 to 910 148 to 1       148/148
(100 %)
0 diff
(100 %id)
EH346164   .o 768 to 818 1 to 51       51/51
(100 %)
0 diff
(100 %id)
GD155460   .o 833 to 920 1 to 88   AAA Possibly primed on the genome, locally A rich (27/27 A in genome downstream of last aligned base) 88/88
(100 %)
6 diff
(93.2 %id)
EC473131 Prostate .o 844 to 909 65 to 3       63/66
(95 %)
0 diff
(100 %id)
AV683814 hepatocellular carcinoma .p 1 to 672 1 to 664 E47V M48L L49G G50S S51R ... tiling clone,   664/664
(100 %)
12 diff
(98.2 %id)
AV687881 hepatocellular carcinoma .p 1 to 415 1 to 410 G31R V40E E42D E47V M48L ...     410/410
(100 %)
14 diff
(96.6 %id)
AV687884 hepatocellular carcinoma .p 1 to 415 1 to 411 E47V M48L L49G G50S S51R ... tiling clone,   411/416
(98 %)
4 diff
(99.1 %id)
DA967326 stomach .q 1 to 576 2 to 577   tiling clone, capped   576/576
(100 %)
1 diff
(99.9 %id)
DB334535 stomach .q 2557 to 3089 535 to 1   tiling clone,   535/535
(100 %)
3 diff
(99.5 %id)
DB064454 testis .r 1 to 557 2 to 559 exact tiling clone, capped   558/558
(100 %)
1 diff
(99.9 %id)
BM311466 Pancreas, Purified pancreatic islet .r 440 to 940 502 to 1   tiling clone,   502/502
(100 %)
1 diff
(99.9 %id)
AI765242 2 pooled tumors (clear cell type), Kidney .r 440 to 940 508 to 8   tiling clone,   501/508
(98 %)
0 diff
(100 %id)
BP210606 cerebellum .s 1 to 584 1 to 584 exact tiling clone,   584/584
(100 %)
1 diff
(99.9 %id)
AW970492   Gene VKORC1andPRSS53, variant not shown         Suspected internal deletion, this clone was ignored    
ES313935 beard hair, skin Gene VKORC1andPRSS53, variant not shown         Suspected internal deletion, this clone was ignored    
BU169459 large cell carcinoma, lung Gene VKORC1andPRSS53, variant not shown         This clone was ignored    
DB031316 testis Gene VKORC1andPRSS53, variant not shown       capped This clone was ignored    
DB337049 testis Gene VKORC1andPRSS53, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC